Homogeneity of active demyelinating lesions in established multiple sclerosis

@article{Breij2008HomogeneityOA,
  title={Homogeneity of active demyelinating lesions in established multiple sclerosis},
  author={Esther C. W. Breij and Bianca P Brink and Robert Veerhuis and Christa van den Berg and Rianka P. M. Vloet and Riqiang Yan and Christine D. Dijkstra and Paul Van Der Valk and Lars B{\"o}},
  journal={Annals of Neurology},
  year={2008},
  volume={63}
}
Four different patterns of demyelination have been described in active demyelinating lesions of multiple sclerosis (MS) patients that were biopsied shortly after disease onset. These patterns were suggested to represent heterogeneity of the underlying pathogenesis. The aim of this study was to determine whether lesion heterogeneity also exists in an unselected collection of autopsy material from patients with established MS. 
Pathologic heterogeneity persists in early active multiple sclerosis lesions
TLDR
Tissue samples collected longitudinally were analyzed to determine whether patterns of demyelination persist over time within a given patient, and to suggest a time‐dependent heterogeneity of lesions.
Iron Heterogeneity in Early Active Multiple Sclerosis Lesions
TLDR
Iron distribution is altered in MS patients' brains, suggesting iron liberation within active lesions amplifies demyelination and neurodegeneration.
Demyelination and Remyelination in Multiple Sclerosis
TLDR
The aim of this review is to give a brief account of the histopathology of demyelination and remyelinated in MS, with an emphasis on some issues of current interest in MS pathology research, including MS lesion staging, pathological heterogeneity, gray matter pathology, and axonal loss.
Current concepts in the neuropathology and pathogenesis of multiple sclerosis.
  • G. Moore
  • Medicine, Psychology
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  • 2010
TLDR
Magnetic resonance imaging, together with histopathologic studies, will continue to shed light on the pathogenesis of these focal and diffuse abnormalities in MS.
Current Concepts in the Neuropathology and Pathogenesis of Multiple Sclerosis
  • G. R. Wayne Moore
  • Medicine, Psychology
    Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  • 2010
TLDR
Magnetic resonance imaging, together with histopathologic studies, will continue to shed light on the pathogenesis of these focal and diffuse abnormalities in MS.
Pathogenesis and treatment of multiple sclerosis (MS)
TLDR
The main clinical aspects and the basic features of the MS (Multiple sclerosis) with diagnosis, including the new McDonald criteria and the treatment approach are discussed, and newer targets for the treatment of MS are reviewed.
Immunologic aspects of multiple sclerosis.
TLDR
The immunopathogenic role played by various lymphocyte subsets and their cytokine products in the onset and disease progression, and the role of regulatory immune cells in disease remission are reviewed.
The immunopathophysiology of multiple sclerosis.
MULTIPLE SCLEROSIS PATHOPHYSIOLOGY UPDATE
TLDR
This discussion explores the immunopathologic origins of MS and how the immunologic cascade of cellular events relates to disease progression/compensation and the current therapeutic approach.
...
...

References

SHOWING 1-10 OF 32 REFERENCES
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
TLDR
Clinical and pathological findings in 12 patients with relapsing and remitting multiple sclerosis, who died during or shortly after the onset of a relapse, raise the possibility of some novel process underlying new lesion formation in multiple sclerosis.
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
TLDR
At a given time point of the disease, the patterns of demyelination were heterogeneous between patients, but were homogenous within multiple active lesions from the same patient, suggesting that MS may be a disease with heterogeneous pathogenetic mechanisms.
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
TLDR
A case of multiple sclerosis characterized by deposition of immunoglobulin and complement in the areas of active demyelination and degradation products that were immunoreactive for myelin antigens, Immunoglobulins, and C9neo antigen were described.
Immunopathology of secondary‐progressive multiple sclerosis
TLDR
Findings suggest that slowly expanding lesions (progressive plaques), in which ongoing myelin breakdown occurs in the absence of florid perivascular cell cuffing or other histological signs of acute inflammation, contribute to disease progression in cases of secondary‐progressive multiple sclerosis.
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease
TLDR
Most patients undergoing biopsy, who had pathologically confirmed demyelinating disease, were likely to develop MS and remain ambulatory after a median disease duration of 4.4 years, and data suggest that pathogenic implications derived largely from MS biopsy studies may be extrapolated to the general MS population.
Identification of autoantibodies associated with myelin damage in multiple sclerosis
TLDR
These findings represent direct evidence that autoantibodies against a specific myelin protein mediate target membrane damage in central nervous system demyelinating disease.
The pathology of multiple sclerosis: a paradigm shift
TLDR
Recent pathological studies raise important questions regarding the aetiology of oligodendrocyte apoptosis, the mechanisms by which the accompanying inflammatory response amplifies tissue injury and the regulation of central nervous system immunity.
Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.
TLDR
Investigation of immunopathology in autopsy tissue of 14 patients with acute multiple sclerosis or fulminant exacerbations of chronic multiple sclerosis with Baló-type lesions in the CNS found that all active concentric lesions followed a pattern of demyelination that bears resemblances to hypoxia-like tissue injury.
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis
TLDR
Overall these findings suggest a pathogenic antibody response to native MOG in a subgroup of MS patients, and its implication for demyelination and axonal loss in MS.
Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases
TLDR
Brain white matter lesions presenting with MAG loss and apoptotic-like oligodendrocyte destruction, irrespective of their primary disease cause, revealed a prominent nuclear expression of hypoxia inducible factor-1α in various cell types, including oligodendedrocytes.
...
...